Merger Notification - Announcement according to § 10 Cartel Act

Rose DS Investment LP; Medi-Globe Corporation - BWB/Z-2987 | Bundeswettbewerbsbehörde

Rose DS Investment LP; Medi-Globe Corporation

BWB/Z-2987

11.03.2016

On the following merger was notified at the Federal Competition Authority:

Planned purchase process

​The notified transaction concerns the acquisition of 88.29% of the shares in and sole control over Medi-Globe Corporation (United States) and its subsidiaries by Rose DS Investment LP, a company recently set up and ultimately controlled by Duke Street LLP (United Kingdom). Funds ultimately controlled by Deutsche Bank AG (Germany) will hold more than 50% and subsidiaries of Allstate Corp. (United States) will hold more than 25% of the limited partnership interests of Rose DS Investment LP.The concentration concerns medical devices for gastroenterological and urological treatments and disposable products for hospitals.

Industry sector: C - Verarbeitendes Gewerbe/Herstellung von Waren

Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 08.04.2016.

Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.

Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.

Non-prohibition of the merger

The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 08.04.2016 .

back to list